Immunoassay development guidelines for neurodegenerative disorders:lessons from a failed pS129-α-synuclein electrochemiluminescence immunoassay  

作　　者：Hash Brown Taha Alanna Morris 

机构地区：[1]Leonard Davis School of Gerontology,University of Southern California,Los Angeles,CA,USA [2]Deparmtent of Neurobiology,David Geffen School of Medicine,University of California Los Angeles,Los Angeles,CA,USA

出　　处：《Neural Regeneration Research》2025年第10期2906-2908,共3页中国神经再生研究（英文版）

摘　　要：An aging population is a double-edged sword.On one hand,advancements in biotechnology and healthcare allow more people to enjoy longer lives.On the other hand,increases in the aging population accompany a surge in age-associated diseases,particularly neurodegenerative disorders.Since aging is the primary risk factor for many neurodegenerative disorders,living longer does not necessarily equate to maintaining a reasonable quality of life(Feigin et al.,2020).

关 键 词：AGING DEGENERATIVE necessarily 

分 类 号：R741[医药卫生—神经病学与精神病学]